Clinical trial
Phase 1 Study of Apatinib as an Inhibitor of Angiogenesis
NCT00633490 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Study of Apatinib as an Inhibitor of Angiogenesis
- Lead sponsor
- Fudan University
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- July 31, 2007
- Completion date
- June 30, 2008
- Enrollment
- 18 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tumor